Natixis Advisors’s Natus Medical Inc NTUS Stock Holding History

Natixis Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-75,784	Closed	-$2.58M	–	1106
2018 Q4	$2.58M	Buy	+75,784	New	+$2.46M	0.03%	626

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Natixis Advisors's NTUS Position: Q1 2019 in Review

Natixis Advisors sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 75,784 shares — an estimated $2.58M sold.

Natixis Advisors first reported a position in NTUS in Q4 2018 and held it in 1 quarter. The position peaked at $2.58M in Q4 2018. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

Natixis Advisors reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
Natixis Advisors sold 75,784 Natus Medical Inc shares in Q1 2019, an estimated $2.58M.
Natixis Advisors first reported a position in Natus Medical Inc in Q4 2018 and held it in 1 quarter.
Natixis Advisors's Natus Medical Inc position peaked at $2.58M in Q4 2018.
168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Natixis Advisors's 13F filing for Q1 2019, filed 15 May 2019.